Candida auris infections in an intensive care unit: Antifungal resistance, mortality rates and infection control interventions
- PMID: 40512568
- DOI: 10.1556/030.2025.02615
Candida auris infections in an intensive care unit: Antifungal resistance, mortality rates and infection control interventions
Abstract
Candida auris spreads rapidly and causes outbreaks worldwide. Strict infection control is critical to control its spread; however, it is challenging and requires a special approach. This study aims to investigate the colonization and infection of C. auris in intensive care units (ICUs), analyses its susceptibility, and mortality rates, and contributes to an effective infection control.An infection control study was planned, and a C. auris infection control bundle and checklist were developed. During the study's pre-intervention, intervention, and post-intervention periods, C. auris candidemia cases and colonized patients were identified. Until the infection control intervention, all the candidemia cases, antifungal resistance, and mortality were investigated retrospectively. Clinical isolates were identified by phenotypic and genotypic characterization using MALDI-TOF MS Biotyper (Bruker Daltonics, Bremen, Germany) and sequencing.During the pre-intervention, intervention, and post-intervention periods, 26 C. auris cases were identified. Pan-resistant C. auris isolates were 3.84%, and the multidrug resistance was 65.38%. With the infection control intervention, the number of colonized patients decreased (pre-intervention 9.61‰, intervention 6.19‰, post-intervention 5.20‰). Candidemia incidence decreased from 4.09 to 2.3‰. No new cases of candidemia were observed at the end of the study.The risk of new cases is elevated in the rooms where multiple C. auris cases have been previously isolated. Mortality rate was high; namely, 76.92% of patients died, and 19.23% of strains were resistant to anidulofungin, one of the most commonly used antifungals. Despite the short implementation period, the infection control bundle and checklist have been demonstrated to be effective in controlling C. auris spread in the ICU.
Keywords: Candida auris; infection control; intensive care unit; mortality; outbreaks; resistance.
Similar articles
-
Impact of Candida auris on Critically Ill Patients: A Three-Year Observational Study in a Greek Intensive Care Unit.Pathogens. 2025 Mar 28;14(4):328. doi: 10.3390/pathogens14040328. Pathogens. 2025. PMID: 40333088 Free PMC article.
-
A clinical and molecular analysis of Candidozyma auris strains from Romania, 2022-2023.Microbiol Spectr. 2025 Jul;13(7):e0280924. doi: 10.1128/spectrum.02809-24. Epub 2025 May 19. Microbiol Spectr. 2025. PMID: 40387391 Free PMC article.
-
Identification and antifungal resistance profiling of Candida (Candidozyma) auris in a tertiary hospital in Istanbul, Türkiye.Ann Saudi Med. 2025 Jul-Aug;45(4):207-217. doi: 10.5144/0256-4947.2025.207. Epub 2025 Aug 7. Ann Saudi Med. 2025. PMID: 40753464 Free PMC article.
-
Activity of rezafungin against Candida auris.J Antimicrob Chemother. 2025 Jun 3;80(6):1482-1493. doi: 10.1093/jac/dkaf124. J Antimicrob Chemother. 2025. PMID: 40304092 Free PMC article. Review.
-
Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID-19) patients: A systematic review.Mycoses. 2022 Jun;65(6):613-624. doi: 10.1111/myc.13447. Mycoses. 2022. PMID: 35441748 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical